Insights into the development of alcoholic chronic pancreatitis at Soweto, South Africa: A controlled cross-sectional study

Pancreas

Volumn 40, Issue 4, 2011, Pages 508-516

  Segal, Isidor ^a,g   Ally, Reid ^a   Hunt, Linda P ^b   Sandle, Lance N ^c   Ubbink, Johan B ^d,h   Braganza, Joan M ^e,f  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c TRAFFORD GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF PRETORIA   (South Africa)

^e MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^f Core Technology Facility ^*  (United Kingdom)

^g PRINCE OF WALES HOSPITAL   (Australia)

^h Dr WJH Vermaak Incorporated Pathologists   (South Africa)

Author keywords

Alcoholic chronic pancreatitis; Bantu siderosis; electrophilic stress; homocysteine; micronutrient status; occupational xenobiotics

Indexed keywords

ALCOHOL; ASCORBIC ACID; CYANOCOBALAMIN; FOLIC ACID; GLUTATHIONE; PYRIDOXINE; SULFATE; XENOBIOTIC AGENT;

ACUTE PSYCHOSIS; ADULT; AGED; ALCOHOLIC PANCREATITIS; ARTICLE; CHRONIC PANCREATITIS; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ELECTROPHILIC STRESS; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; IRON OVERLOAD; LIFESTYLE; MALE; NORMAL HUMAN; NUTRITIONAL STATUS; PRIORITY JOURNAL; SOUTH AFRICA;

ADULT; ANALYSIS OF VARIANCE; ASCORBIC ACID; CROSS-SECTIONAL STUDIES; FEMALE; GLUTATHIONE; HUMANS; MALE; MIDDLE AGED; PANCREATITIS, CHRONIC; RISK ASSESSMENT; RISK FACTORS; SOUTH AFRICA; SULFATES; XENOBIOTICS; YOUNG ADULT;

EID: 79955064473     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e318214f94a     Document Type: Article

References (51)

1. Friedrich N. Disease of the pancreas. In: Ziemsen H, ed. Cyclopaedia of the Practice of Medicine. New York: William Wood; 1878:549-630.
2. DiMagno MJ, Wamsteker E-J, Lee A. Chronic pancreatitis. BMJ Best Practice. 2010. Available at: http://bestpractice.bmj.com/best-practice/ momograph/67/highlights.html. Accessed February 12, 2010
3. Segal I. Pancreatitis in Soweto, South Africa. Focus on alcohol-relate disease. Digestion. 1998; 59(suppl 4):25-35. (Pubitemid 28548605)
4. Chowdhury P, Gupta P. Pathophysiology of alcoholic pancreatitis: an overview. World J Gastroenterol. 2006; 12:7421-7427. (Pubitemid 46017737)
5. Pandol SJ, Rarity M. Pathobiology of alcoholic pancreatitis. Pancreatology. 2007; 7:105-114. (Pubitemid 47094078)
6. Tattersall SJN, Apte MV, Wilson JS. A fire inside: current concepts in chronic pancreatitis. Int Med J. 2008; 38:592-598.
7. Braganza JM, Dormandy TL. Micronutrient therapy for chronic pancreatitis: rationale and impact. JOP. 2010; 11:99-112.
8. Yadav D, Hawes RH, Brand RE, et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Int Med. 2009; 169:1035-1045.
9. McNamee R, Braganza JM, Hogg J, et al. Occupational exposure to hydrocarbons and chronic pancreatitis: a case-referent study. Occup Environ Med. 1994; 51:631-637.
10. Chen J-M, Férec C. Chronic pancreatitis: genetics and pathogenesis. Annu Rev Genomics Hum Genet. 2009; 63-87.
11. Aoyagi H, Okada T, Hasatani K, et al. Impact of cystic fibrosis transmembrane conductance regulator gene mutation on the occurrence of chronic pancreatitis in Japanese patients. J Int Med Res. 2009; 37:378-384.
12. Maruyama K, Harada S, Yokoyama A, et al. Association analyses of genetic polymorphisms of GSTM1, GSTT1, NQO1, NAT2, LPL, PRSS1, PSTI, and CFTR with chronic alcoholic pancreatitis in Japan [published online ahead of print November 5, 2009]. Alcohol Clin Exp Res. 2010; 34(suppl 1):S34-S38.
13. Segal I, Sharer NM, Kay PM, et al. Iron, ascorbate and copper status of Sowetan blacks with calcific chronic pancreatitis. QJM. 1996; 89:45-53. (Pubitemid 26023963)
14. Ubbink JB, Vermaak HWJ, van der Merwe A, et al. Vitamin requirements for the treatment of hyperhomocystenaemia in humans. J Nutr. 1994; 124:1927-1933. (Pubitemid 24334627)
15. Gut A, Shiel N, Kay PM, et al. Heightened free radical activity in blacks with chronic pancreatitis at Johannesburg, South Africa. Clin Chim Acta. 1994; 230:189-199. (Pubitemid 24319744)
16. Segal I, Gut A, Schofield D, et al. Micronutrient antioxidant status in black South Africans with chronic pancreatitis: opportunity for prophylaxis. Clin Chim Acta. 1995; 239:71-79.
17. Axon ATR, Classen M, Cotton PB, et al. Pancreatography in chronic pancreatitis: international definitions. Gut. 1984; 25:1107-1112. (Pubitemid 14002128)
18. Chaloner C, Segal I, Hassan H, et al. A preliminary report on urinary BT-PABA/PAS excretion index, serum pancreatic isoamylase and faecal chymotrypsin tests of pancreatic dysfunction in Sowetan Africans. Clin Chim Acta. 1995; 233:89-99.
19. Uden S, Schofield D, Miller PF, et al. Antioxidant therapy for recurrent pancreatitis: biochemical profiles in a placebo-controlled trial. Aliment Pharmacol Ther. 1992; 6:229-240.
20. Schofield D, Guyan PM, Braganza JM. Problems with the quantitative analysis of dehydroascorbic acid and ascorbic acid in plasma by HPLC. Biochem Soc Trans. 1990; 18:1179-1180.
21. Schofield D, Mei G, Braganza JM. Some pitfalls in the measurement of blood glutathione. Clin Sci. 1993; 85:213-218. (Pubitemid 23243882)
22. Sandle LN, Braganza JM. An evaluation of the low-pH enzymatic assay for urinary D-glucaric acid, and its use as a marker of enzyme induction in exocrine pancreatic disease. Clin Chim Acta. 1987; 162:245-256. (Pubitemid 17050068)
23. Ubbink JB, Serfontein WJ, de Villiers LS. Stability of pyridoxyl-5-phosphate semicarbazone: application in plasma vitamin B-6 analysis and population surveys of vitamin B-6 nutritional status. J Chromatogr. 1985; 342:277-284. (Pubitemid 15243671)
24. Ubbink JB, Vermark WJH, Bissbort S. Rapid high performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr. 1991; 565:441-446.
25. Siegel S, Castellan NJ. Nonparametric Statistics for the Behavioral Sciences. 2nd ed. London: McGraw-Hill; 1989:213-214. Second printing.
26. Zabry ZI, Shadarevian SB, Cowan JW, et al. Relationship of dietary intake of sulphur amino acids to urinary excretion of inorganic sulphate in man. Nature. 1965; 206:931-933.
27. Veghelyi PV, Kemeny TT, Pozsonyi J, et al. Toxic lesions of the pancreas. Am J Dig Dis. 1950; 80:390-403.
28. Frulloni L, Gabrielli A, Pezzilli R, et al. Chronic pancreatitis: report from a multicenter Italian survey (PanCroInfAISP) on 893 patients. Dig Liver Dis. 2009; 41:311-317.
29. Whitcomb DC, Yadav D, Adam S, et al. Multicenter approach to recurrent acute and chronic pancreatitis in the Unites States: the North American Pancreatitis Study 2 (NAPS2). Pancre atology. 2008; 8:520-531.
30. Jeppe CY, Smith MD. Transverse descriptive study of xenobiotic exposures in patients with chronic pancreatitis and pancreatic cancer. JOP. 2008; 9:235-239. (Pubitemid 351611742)
31. Braganza JM, John S, Padmayalam I, et al. Xenobiotics and tropical pancreatitis. Int J Pancreatol. 1990; 7:231-245.
32. Merkord J, Weber H, Sparmann G, et al. The course of pancreatic fibrosis induced by dibutyltin dichloride (DBTC). Ann NY Acad Sci. 1999; 880:231-237. (Pubitemid 29349131)
33. Wallig MA. Xenobiotic metabolism, oxidant stress and chronic pancreatitis. Digestion. 1998; 59(suppl 4):13-24. (Pubitemid 28548604)
34. Foster JR. Toxicology of the pancreas. In: Ballantyne B, Marrs Syversen T, eds. General and Applied Toxicology. 3rd ed. Chichester: John Wiley; 2009:1411-1155.
35. Powers HJ, Loban A, Silvers K, et al. Vitamin C at concentrations observed in premature babies inhibits the ferroxidase activity of caeruloplasmin. Free Rad Res Commun. 1995; 22:57-65.
36. Girish BN, Vaidyanathan K, Rao NA, et al. Chronic pancreatitis is associated with hyperhomocysteinemia and derangements in transsulfuration and transmethylation pathways. Pancreas. 2010; 39:e11-e16.
37. Braganza JM, Odom N, McCloy RF, et al. Hyperhomocystenaemia and chronic pancreatitis. Pancreas. 2010; 39:1303-1304.
38. Verlaan M, Roelofs HMJ, van Schaik A, et al. Assessment of oxidative stress in chronic pancreatitis patients. World J Gastroenterol. 2006; 12:5705-5710. (Pubitemid 44594048)
39. Strubelt O. Interaction between ethanol and other hepatotoxic agents. Biochem Pharmacol. 1980; 29:1445-1449. (Pubitemid 10101893)
40. Lieber CS. The discovery of the microsomal ethanol oxidizing system and its physiologic and pathological role. Drug Metab Rev. 2004; 36:511-529. (Pubitemid 39453060)
41. Gonzalez FJ. Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. Mutat Res. 2005; 569: 101-110. (Pubitemid 39643260)
42. Braganza JM, Hewitt C, Day JP. Serum selenium concentration in chronic pancreatitis: lowest values during painful exacerbations. Trace Elements Med. 1988; 42:79-84.
43. Gut A, Chaloner C, Schofield D, et al. Evidence of toxic metabolite stress in blacks with 'alcoholic' chronic pancreatitis at Soweto, RSA. Clin Chim Acta. 1995; 236:145-153.
44. Szuster-Ciesielka A, Plewka K, Daniluk J, et al. Zinc supplementation attenuates ethanol- and acetaldehyde-induced liver stellate cell activation by inhibiting reactive oxygen species (ROS) production and by influencing intracellular signaling. Biochem Pharmacol. 2009; 78:301-314.
45. Ubbink JB. Metabolic markers of vitamin nutritional status. Am J Clin Nutr. 1999; 70:789-790. (Pubitemid 29512900)
46. Braganza JM. A framework for the aetiogenesis of chronic pancreatitis. Digestion. 1998; 59(suppl 4):1-12. (Pubitemid 28548603)
47. McCloy RF. Chronic pancreatitis at Manchester, UK. Focus on antioxidant therapy. Digestion. 1998; 59(suppl 4):36-48.
48. Shah NS, Makin AJ, Sheen AJ, et al. Quality of life assessment in patients with chronic pancreatitis receiving antioxidant therapy. World J Gastroenterol. 2010; 16:4066-4071.
49. Uomo G, Talamini G, Rabitti PG. Antioxidant treatment in hereditary pancreatitis. A pilot study in three young patients. Dig Liver Dis. 2001; 33:58-62. (Pubitemid 32186176)
50. Sharer N, Schwarz M, Malone G, et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med. 1998; 339:645-652. (Pubitemid 28402088)
51. Midha S, Khajuria R, Shastri S, et al. Idiopathic chronic pancreatitis in India: phenotypic characterization and strong genetic susceptibility due to SPINK1 and CFTR gene mutations. Gut. 2010; 59:800-807.